Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia-Reference-Cited by-同舟云学术

Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia

Published:2018-04-02 Issue:10 Volume:78 Page:743-752
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Inamura So¹²^ORCID,Ito Hideaki¹,Shinagawa Tomochika¹²,Tsutsumiuchi Manami¹²,Taga Minekatsu¹²,Kobayashi Motohiro²^ORCID,Yokoyama Osamu¹

Affiliation:

1. Department of Urology, Faculty of Medical Sciences; University of Fukui; Eiheiji Japan

2. Department of Tumor Pathology, Faculty of Medical Sciences; University of Fukui; Eiheiji Japan

Publisher

Wiley

Subject

Urology,Oncology

Reference16 articles.

1. Inflammation in benign prostatic hyperplasia: a 282 patients’ immunohistochemical analysis;Robert;Prostate,2009

2. Experience with uroflowmetry in evaluation of lower urinary tract symptoms in patients with benign prostatic hyperplasia;Singla;J Clin Diagn Res,2014

3. Prostatic inflammation in benign prostatic hyperplasia-the third component;Nickel;Can J Urol,1994

4. The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial;Nickel;Eur Urol,2008

5. Consensus development of a histopathological classification system for chronic prostatic inflammation;Nickel;BJU Int,2001

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrinsic and extrinsic factors causing hyperplasia of the prostate;International Journal of Urology;2024-03-10

2. Perioperative changes in ganglioside monosialodihexosylganglioside (GM3) molecular species for benign prostatic hyperplasia: a preliminary report;Translational Andrology and Urology;2024-01

3. Effects of algerian nettle ( Urtica dioica L.) on benign prostatic hyperplasia and their mechanism of action elucidation: in vivo and in silico approaches;Natural Product Research;2023-10-22

4. Association between interleukin-6 and lower urinary tract symptoms of benign prostatic hyperplasia;Revista Internacional de Andrología;2023-04

5. Treatment with the soluble guanylate cyclase activator BAY 60–2770 normalizes bladder function in an in vivo rat model of chronic prostatitis;European Journal of Pharmacology;2022-07